Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants.

Alzheimers Res Ther · 2023 · PMC10571241 · PMID 37833762

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Though it is unlikely that APOE ε4 status will have a pivotal role in the clinical diagnosis of AD, APOE ε4 assessment may be significant with the arrival of anti-Aβ DMTs, as APOE ε4 carriers have higher incidence of ARIA [ 71 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.